DUBLIN–(BUSINESS WIRE)–The “Global Targeted Therapeutics Market 2021-2026” report has been added to ResearchAndMarkets.com’s offering.
The global market for targeted therapeutics is forecast to grow from $100.9 billion in 2021 to $142.6 billion by 2026, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2021-2026.
The global market for small molecules should grow from $60.3 billion in 2021 to $83.1 billion by 2026, at a CAGR of 6.6% during the forecast period of 2021-2026.
The global market for monoclonal antibodies should grow from $40.6 billion in 2021 to $59.5 billion by 2026, at a CAGR of 8.0% during the forecast period of 2021-2026.
Report Scope
- The scope of this study entails the worldwide market for targeted therapeutics. The report covers the entire market for targeted therapeutics, which incorporates two main types, small molecules and monoclonal antibodies. Based on application, targeted therapeutics is divided into lung cancer, breast cancer, blood cancer, colorectal cancer and others.
- By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries: the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered.
- For market estimates, data has been provided for the year 2020 as the base year, with forecasts for 2021-2026. Estimated values are based on drug manufacturer total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
The Report Includes
- 24 data tables and 29 additional tables
- An overview of the global market for targeted therapeutics within the biopharmaceuticals sector
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market size and market forecast for targeted therapeutics, technological advancements, and corresponding market share analysis by type, application and geographic region
- A detailed description of the target-specific functionality, advantages of target therapeutics, their production and processes, and discussion on their ability to provide therapeutic treatments for various chronic diseases
- Coverage of disease and economic burden of cancer, types of cancer therapy and insights into cancer treatment strategy timeline
- Insight into global R&D activities related to oncology drugs, industry structure, product launches, clinical trials, and regulatory scenarios affecting the future marketplace
- Competitive landscape and pipeline analysis of the key companies operating in the global market, their company share analysis, and relevant oncology drug licensing deals and M&A deals
-
Company profiles of major industry players, including Amgen Inc., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), F. Hoffmann-La Roche Ltd., Pfizer, Novartis, Merck & Co., and Takeda Pharmaceutical Co., Ltd.
Key Topics Covered:
Market Overview
- Cancer Burden
- Causes of Cancer
- Genetic Factors
- Lifestyle Factors
- Environmental Factors
- Cancer-Causing Genes
- Immune System and Cancer
- Cancer Prevention
- Types of Cancer Treatment
- Non-pharmacological Approaches
- Pharmacological Approaches
- Gene Therapy
- Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact of COVID-19 on Market
Regulatory Aspects
- United States
- New Drug Application (NDA)
- Fast-Track Status
- Europe
- Japan
- India
- New Drug Approval
- Import Registration Certificate
- Import License
- China
Company Profiles
- Amgen Inc.
- Astrazeneca
- Bayer Ag
- Boehringer Ingelheim International Gmbh
- Bristol-Myers Squibb
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Novartis Ag
- Pfizer
- Takeda Pharmaceutical Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/78tby
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900